L'asphyxie nécessite une réanimation immédiate et une surveillance en soins intensifs néonatals.
Asphyxie néonataleRéanimation néonatale
#3
Quels sont les risques d'infections néonatales ?
Les nouveau-nés sont vulnérables aux infections, surtout s'ils sont prématurés ou de faible poids.
Infections néonatalesPoids de naissance faible
#4
Comment reconnaître une jaunisse néonatale ?
La jaunisse se manifeste par une coloration jaune de la peau et des yeux, nécessitant une évaluation.
Jaunisse néonataleÉvaluation néonatale
#5
Quels sont les signes d'une infection à la naissance ?
Les signes incluent une température instable, une irritabilité et des difficultés à s'alimenter.
Infection néonataleIrritabilité
Facteurs de risque
5
#1
Quels facteurs augmentent le risque de prématurité ?
Les antécédents de prématurité, les infections et les problèmes de santé maternels augmentent le risque.
PrématuritéAntécédents médicaux
#2
Comment l'âge maternel influence-t-il la grossesse ?
Les grossesses chez les femmes très jeunes ou plus âgées peuvent présenter des risques accrus de complications.
Âge maternelComplications de grossesse
#3
Quels comportements à risque affectent la grossesse ?
Le tabagisme, l'alcool et la consommation de drogues peuvent nuire à la santé du fœtus.
TabagismeSanté fœtale
#4
Comment les maladies chroniques influencent-elles la grossesse ?
Les maladies comme le diabète ou l'hypertension peuvent augmenter le risque de complications à la naissance.
Maladies chroniquesComplications néonatales
#5
Quels facteurs socio-économiques influencent la grossesse ?
Un faible statut socio-économique peut limiter l'accès aux soins prénatals et augmenter les risques.
Statut socio-économiqueSoins prénatals
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Naissance vivante : Questions médicales les plus fréquentes",
"headline": "Naissance vivante : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Naissance vivante : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-05",
"dateModified": "2025-11-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Naissance vivante"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Issue de la grossesse",
"url": "https://questionsmedicales.fr/mesh/D011256",
"about": {
"@type": "MedicalCondition",
"name": "Issue de la grossesse",
"code": {
"@type": "MedicalCode",
"code": "D011256",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G08.686.784.769.496"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Naissance vivante",
"alternateName": "Live Birth",
"code": {
"@type": "MedicalCode",
"code": "D050498",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xiufeng Ling",
"url": "https://questionsmedicales.fr/author/Xiufeng%20Ling",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Reproductive Medicine."
}
},
{
"@type": "Person",
"name": "Jichun Tan",
"url": "https://questionsmedicales.fr/author/Jichun%20Tan",
"affiliation": {
"@type": "Organization",
"name": "Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, China."
}
},
{
"@type": "Person",
"name": "Joan A Casey",
"url": "https://questionsmedicales.fr/author/Joan%20A%20Casey",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY."
}
},
{
"@type": "Person",
"name": "Michael Olausson",
"url": "https://questionsmedicales.fr/author/Michael%20Olausson",
"affiliation": {
"@type": "Organization",
"name": "Department of Transplantation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden."
}
},
{
"@type": "Person",
"name": "Rui Huang",
"url": "https://questionsmedicales.fr/author/Rui%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Reproductive Medicine Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Season and temperature do not affect cumulative live birth rate and time to live birth in",
"datePublished": "2023-06-21",
"url": "https://questionsmedicales.fr/article/37424872",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1156299"
}
},
{
"@type": "ScholarlyArticle",
"name": "Estradiol on trigger day: Irrelevant to live birth rates of fresh cycles but positively associated with cumulative live birth rates.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37222253",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijgo.14887"
}
},
{
"@type": "ScholarlyArticle",
"name": "First live birth after uterine transposition.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36863432",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.fertnstert.2023.02.033"
}
},
{
"@type": "ScholarlyArticle",
"name": "Time to live birth: towards a common agreement.",
"datePublished": "2023-04-18",
"url": "https://questionsmedicales.fr/article/37071319",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10815-023-02790-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Emergency Preparedness in Tennessee Women with a Recent Live Birth.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/36995650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10995-023-03649-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques des appareils urinaire et reproducteur",
"item": "https://questionsmedicales.fr/mesh/D012101"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques de la reproduction",
"item": "https://questionsmedicales.fr/mesh/D055703"
},
{
"@type": "ListItem",
"position": 4,
"name": "Reproduction",
"item": "https://questionsmedicales.fr/mesh/D012098"
},
{
"@type": "ListItem",
"position": 5,
"name": "Grossesse",
"item": "https://questionsmedicales.fr/mesh/D011247"
},
{
"@type": "ListItem",
"position": 6,
"name": "Issue de la grossesse",
"item": "https://questionsmedicales.fr/mesh/D011256"
},
{
"@type": "ListItem",
"position": 7,
"name": "Naissance vivante",
"item": "https://questionsmedicales.fr/mesh/D050498"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Naissance vivante - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Naissance vivante",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Naissance vivante",
"description": "Comment confirmer une naissance vivante ?\nQuels examens sont réalisés après la naissance ?\nQuelles sont les indications d'une naissance vivante ?\nComment évaluer l'état de santé du nouveau-né ?\nQuels sont les critères de viabilité ?",
"url": "https://questionsmedicales.fr/mesh/D050498#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Naissance vivante",
"description": "Quels signes indiquent une naissance vivante ?\nComment reconnaître un nouveau-né en bonne santé ?\nQuels symptômes peuvent indiquer des complications ?\nQuels sont les signes d'une détresse néonatale ?\nComment évaluer la température du nouveau-né ?",
"url": "https://questionsmedicales.fr/mesh/D050498#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Naissance vivante",
"description": "Comment prévenir les complications à la naissance ?\nQuels conseils pour une grossesse saine ?\nComment réduire le risque de prématurité ?\nQuels examens prénataux sont recommandés ?\nComment assurer un environnement sûr pour le nouveau-né ?",
"url": "https://questionsmedicales.fr/mesh/D050498#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Naissance vivante",
"description": "Quels soins initiaux sont nécessaires après la naissance ?\nComment traiter les complications respiratoires ?\nQuels vaccins sont administrés à la naissance ?\nComment gérer l'alimentation du nouveau-né ?\nQuels traitements pour les infections néonatales ?",
"url": "https://questionsmedicales.fr/mesh/D050498#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Naissance vivante",
"description": "Quelles sont les complications possibles à la naissance ?\nComment gérer une asphyxie néonatale ?\nQuels sont les risques d'infections néonatales ?\nComment reconnaître une jaunisse néonatale ?\nQuels sont les signes d'une infection à la naissance ?",
"url": "https://questionsmedicales.fr/mesh/D050498#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Naissance vivante",
"description": "Quels facteurs augmentent le risque de prématurité ?\nComment l'âge maternel influence-t-il la grossesse ?\nQuels comportements à risque affectent la grossesse ?\nComment les maladies chroniques influencent-elles la grossesse ?\nQuels facteurs socio-économiques influencent la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D050498#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment confirmer une naissance vivante ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La naissance vivante est confirmée par l'évaluation de la respiration et des battements cardiaques du nouveau-né."
}
},
{
"@type": "Question",
"name": "Quels examens sont réalisés après la naissance ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cliniques et des tests de dépistage sont effectués pour évaluer la santé du nouveau-né."
}
},
{
"@type": "Question",
"name": "Quelles sont les indications d'une naissance vivante ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes vitaux tels que la respiration, le pouls et les réflexes indiquent une naissance vivante."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'état de santé du nouveau-né ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'APGAR est utilisé pour évaluer la santé du nouveau-né à 1 et 5 minutes après la naissance."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de viabilité ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La viabilité est généralement définie par un poids de naissance supérieur à 500 g et une gestation de 22 semaines."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une naissance vivante ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des pleurs, des mouvements et une respiration régulière du nouveau-né."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un nouveau-né en bonne santé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un nouveau-né en bonne santé présente une peau rosée, des réflexes normaux et une bonne tonicité musculaire."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer des complications ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés respiratoires, une cyanose ou une hypotonie peuvent signaler des complications."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une détresse néonatale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une respiration rapide, des bruits respiratoires anormaux et une agitation."
}
},
{
"@type": "Question",
"name": "Comment évaluer la température du nouveau-né ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La température doit être mesurée régulièrement pour détecter une hypothermie ou une hyperthermie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications à la naissance ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi prénatal régulier et une bonne nutrition sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels conseils pour une grossesse saine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'alcool, le tabac et les drogues, et suivre les recommandations médicales sont cruciaux."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de prématurité ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bon contrôle des maladies chroniques et la gestion du stress peuvent réduire le risque de prématurité."
}
},
{
"@type": "Question",
"name": "Quels examens prénataux sont recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échographies, des tests sanguins et des dépistages génétiques sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment assurer un environnement sûr pour le nouveau-né ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement propre, sans fumée et sécurisé est essentiel pour la santé du nouveau-né."
}
},
{
"@type": "Question",
"name": "Quels soins initiaux sont nécessaires après la naissance ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins incluent le maintien de la température, l'évaluation des signes vitaux et l'alimentation."
}
},
{
"@type": "Question",
"name": "Comment traiter les complications respiratoires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications respiratoires peuvent nécessiter une oxygénothérapie ou une ventilation assistée."
}
},
{
"@type": "Question",
"name": "Quels vaccins sont administrés à la naissance ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le vaccin contre l'hépatite B est souvent administré dans les premières heures après la naissance."
}
},
{
"@type": "Question",
"name": "Comment gérer l'alimentation du nouveau-né ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'allaitement maternel est recommandé, mais des formules adaptées peuvent être utilisées si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les infections néonatales ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections peuvent nécessiter des antibiotiques et une surveillance en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles à la naissance ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les infections, les troubles respiratoires et les malformations congénitales."
}
},
{
"@type": "Question",
"name": "Comment gérer une asphyxie néonatale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'asphyxie nécessite une réanimation immédiate et une surveillance en soins intensifs néonatals."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'infections néonatales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nouveau-nés sont vulnérables aux infections, surtout s'ils sont prématurés ou de faible poids."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une jaunisse néonatale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La jaunisse se manifeste par une coloration jaune de la peau et des yeux, nécessitant une évaluation."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une infection à la naissance ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une température instable, une irritabilité et des difficultés à s'alimenter."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de prématurité ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de prématurité, les infections et les problèmes de santé maternels augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge maternel influence-t-il la grossesse ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les grossesses chez les femmes très jeunes ou plus âgées peuvent présenter des risques accrus de complications."
}
},
{
"@type": "Question",
"name": "Quels comportements à risque affectent la grossesse ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'alcool et la consommation de drogues peuvent nuire à la santé du fœtus."
}
},
{
"@type": "Question",
"name": "Comment les maladies chroniques influencent-elles la grossesse ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies comme le diabète ou l'hypertension peuvent augmenter le risque de complications à la naissance."
}
},
{
"@type": "Question",
"name": "Quels facteurs socio-économiques influencent la grossesse ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un faible statut socio-économique peut limiter l'accès aux soins prénatals et augmenter les risques."
}
}
]
}
]
}
Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, China.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California.
From the Center for Reproductive Medicine, Cheeloo College of Medicine, Key Laboratory of Reproductive Endocrinology of the Ministry of Education, and the National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Shandong Key Laboratory of Reproductive Medicine, and Shandong Provincial Clinical Research Center for Reproductive Health, Jinan (J.Y., Y.Q., H.Z., D.W., J.L., T.N., W.Z., K.W., Y.G., Y.S., Z.-J.C.), the Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics (Y.S., Z.-J.C., Y.L., T.Z.), and the Obstetrics and Gynecology Hospital of Fudan University, Shanghai JIAI Genetics and IVF Institute, Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University (X.S., J.F.), Shanghai, the Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, and Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha (F.G., H.M.), the Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction, Ministry of Education, and Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing (R.L.), the Department of Reproductive Medicine, the Affiliated Obstetrics and Gynecology Hospital with Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital (X.L., J.Z.), and the Department of Reproductive Medicine, First Affiliated Hospital of Nanjing Medical University-Jiangsu Province Hospital (X.M., W.W.), Nanjing, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou (H.L., Q.M.), the Center for Reproductive Medicine of Yantai Yuhuangding Hospital, Yantai (C.H.), the Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Key Laboratory of Reproductive Dysfunction Diseases and Fertility Remodeling of Liaoning Province, Shenyang (J.T.), the Center for Reproductive Medicine, Wuhan University, Wuhan (J.Y.), the Department of Reproductive Endocrinology, Key Laboratory of Reproductive Genetics, Ministry of Education, Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, Zhejiang University School of Medicine, Hangzhou (Y.Z.), the Department of Reproductive Health and Infertility, Guangdong Women and Children Hospital, Guangzhou (F.L.), and the Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei (D.C.) - all in China; the Department of Biostatistics, Yale University School of Public Health, New Haven, CT (H.Z.); and the Department of Obstetrics and Gynecology, Penn State College of Medicine, Hershey, PA (R.S.L.).
Recurrent Pregnancy Loss Unit, Capital Region, Copenhagen University Hospital, Rigshospitalet, Fertility Clinic 4071, 2100 Copenhagen Ø, and Hvidovre Hospital, 2650 Hvidovre, Denmark.
Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen N, Denmark.
Department of Gynaecology-and-Obstetrics, Copenhagen University Hospital, Hvidovre Hospital, 2650 Hvidovre, Denmark.
Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut; Department of Obstetrics and Gynecology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Centre for Clinical Epidemiology, Odense University Hospital, Odense, Denmark and Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Kløvervænget 30, Entrance 216, Odense C DK-5000, Denmark. Electronic address: line.joelving@rsyd.dk.
Centre for Clinical Epidemiology, Odense University Hospital, Odense, Denmark and Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Kløvervænget 30, Entrance 216, Odense C DK-5000, Denmark; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences Norwegian University of Science and Technology, Trondheim, Norway.
Centre of Andrology and Fertility Clinic, Odense University Hospital, Odense Denmark and Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
To explore whether season and temperature on oocyte retrieval day affect the cumulative live birth rate and time to live birth....
This was a retrospective cohort study. A total of 14420 oocyte retrieval cycles from October 2015 to September 2019. According to the date of oocyte retrieval, the patients were divided into four grou...
The number of oocytes retrieved was similar among the groups. Other outcomes, including the number of 2PN (P=0.02), number of available embryos (p=0.04), and number of high-quality embryos (p<0.01) we...
Although season has an effect on the embryo, there was no evidence that season or temperature affect the cumulative live birth rate or time to live birth. It is not necessary to select a specific seas...
To assess the effects of estradiol (E2) on trigger day on cumulative live birth rates (CLBRs), and pregnancy outcomes after fresh and frozen-thawed embryo transfer (FET)....
This multicenter retrospective cohort study included 42 315 patients from five reproductive centers. Six subgroups were divided according to E2 on trigger day (<1000, 1000-2000, 2000-3000, 3000-4000, ...
When E2 was <5500 pg/mL, the CLBR increased by 10% for every 1000 pg/mL increase in E2. When E2 was between 5500 and 13 281 pg/mL, CLBR increased by 1.8% for every 1000 pg/mL increase in E2. When E2 w...
CLBR is associated with E2 on trigger day in a segmented manner. Pregnancy and live birth rates in fresh cycles were not associated with E2. The live birth rate in FET cycles was highest when E2 ≥ 500...
To our knowledge, to report the first case of live birth of a child after uterine transposition (UT), pelvic radiotherapy, and subsequent uterine repositioning....
Case report....
Tertiary referral cancer hospital....
A 28-year-old nulligravid woman with left iliac and thoracic synchronous myxoid low-grade liposarcoma, which was resected with close margins....
The patient underwent UT before undergoing pelvic (60 Gy) and thoracic (60 Gy) radiation on October 25, 2018. After radiotherapy, her uterus was reimplanted in the pelvis on February 20, 2019....
The patient became pregnant in June 2021 and experienced an uneventful pregnancy until 36 weeks, when the patient started preterm labor and had a cesarean section delivery on January 26, 2022....
A boy was delivered after a gestation period of 36 weeks and 2 days (2686 g and 46.5 cm), with Apgar scores of 5 and 9, respectively; both mother and child were discharged the following day. After 1 y...
To our knowledge, this case of the first live birth after UT is a proof-of-concept for the viability of UT as a procedure to prevent infertility in patients requiring pelvic radiotherapy....
The major purpose of a couple at the first infertility appointment is to get a healthy baby as soon as possible. From diagnosis and decision on which assisted reproduction technique (ART) and controll...
To assess emergency preparedness (EP) actions in women with a recent live birth....
Weighted survey procedures were used to evaluate EP actions taken by women with a recent live birth responding to an EP question assessing eight preparedness actions as part of the 2016 Tennessee Preg...
Overall, 82.7% [95% Confidence Interval (CI) 79.3%, 86.1%] of respondents reported any preparedness actions, with 51.8% (95% CI 47.2%, 56.4%) completing 1-4 actions. The most common actions were havin...
Most Tennessee women (about 8 in 10 women) with a recent live birth reported at least one EP action. A three-part EP question may be sufficient for assessing preparedness in this population. These fin...
Ovarian stimulation (OS) for...
The aim of this study was to evaluate whether the live birth rate (LBR) per fresh embryo transfer and cumulative live birth rate (CLBR) per aspiration cycle differ in women with PCOS defined by the Pa...
A retrospective study involving 2,377 women with PCOS who underwent their first IVF/ICSI cycle at Sun Yat-sen Memorial Hospital from January 2011 to December 2020 was used. Patients were categorized i...
For patients <35 years old, there was no significant difference in the clinical pregnancy rate between POSEIDON and non-POSEIDON patients, whereas POSEIDON patients exhibited lower rates of implantati...
In patients with PCOS, an unexpected suboptimal response can achieve a fair LBR per fresh embryo transfer. However, CLBR per aspirated cycle in POSEIDON patients was lower than that of normal responde...
The objectives of our study were to investigate the live birth rate (LBR) per oocyte retrieved during in vitro fertilization, in patients who had used all their embryos and to extrapolate the LBR in p...
A retrospective cohort study....
A single academically affiliated fertility clinic....
Autologous in vitro fertilization cycles from January 2014 to December 2020. Data on the number of oocytes retrieved, number of embryos obtained and transferred (at cleavage or blastocyst-stage), use ...
None....
Live birth rate per oocyte retrieved....
A total of 12,717 patients met the inclusion criteria and underwent a total of 20,677 oocyte retrievals which yielded a total of 248,004 oocytes and 57,268 embryos (fresh and frozen). In patients who ...
Despite clinical and scientific advances in Assisted Reproductive Technology, with the current protocols of ovarian stimulation, the LBR per oocyte remains low reflecting a biological barrier that has...
To determine if ovarian responsiveness to gonadotropin stimulation differs by race/ethnicity and whether this predicts live birth rates (LBRs) in non-White patients undergoing in vitro fertilization (...
Retrospective cohort study....
Academic infertility center....
White, Asian, Black, and Hispanic patients undergoing ovarian stimulation for IVF....
Self-reported race and ethnicity....
The primary outcome was ovarian sensitivity index (OSI), defined as (the number of oocytes retrieved ÷ total gonadotropin dose) × 1,000 as a measure of ovarian responsiveness, adjusting for age, body ...
The primary analysis of OSI included 3,360 (70.2%) retrievals from White patients, 704 (14.7%) retrievals from Asian patients, 553 (11.6%) retrievals from Black patients, and 168 (3.5%) retrievals fro...
Black and Hispanic patients have higher ovarian responsiveness to stimulation during IVF but do not experience a consequent increase in LBR. Factors beyond differences in responsiveness to ovarian sti...
To identify factors associated with the definition of the gestational age (GA) estimation method recorded in the live birth certificate (LBC), and to compare the results obtained according to the meth...
Cross-sectional population-based study using the Live Birth Information System. Descriptive and comparative analysis was performed according to the GA estimation method, followed by a univariate and m...
The estimation of GA by the date of the last menstrual period (LMP) (39.9%) was lower than that obtained by other methods (OM) (60.1%) - physical examination and ultrasound, between 2012-2019. LMP reg...
Prematurity was higher with the GA estimated by LMP in the CSP, which may indicate overestimation by this method. The source of funding was the most explanatory variable for defining the GA estimator ...
To investigate whether the presence of vacuoles in biopsied blastocysts is associated with the likelihood of aneuploidy and clinical outcomes....
Retrospective observational study....
A single reproductive center....
None....
This study retrospectively analyzed data obtained through preimplantation genetic testing for aneuploidy performed on 3351 blastocysts from 826 patients at a single reproductive center between August ...
The associations between vacuoles and euploidy or live birth rates were assessed using logistic regression models and estimated adjusted odds ratios (ORs) and 95% confidence intervals (CIs)....
Of the 3351 blastocysts from 826 patients, 903 (26.9%) were discovered to have vacuoles. The vacuole-positive group had a significantly lower percentage of euploid blastocysts after TE biopsy than the...
The formation of vacuoles in blastocysts is associated with lower rates of euploidy and live birth. Blastocysts without vacuoles should thus be prioritized for embryo transfer in vitro fertilization c...